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Health and Welfare
Chapter 321: The Corporate Practice of Medicine Doctrine
and Narcotic Treatment Programs
Carla G. McClurg

Code Sections Affected
Business and Professions Code § 2401 (amended); Health and
Safety Code §§ 11877.6, 11877.7 (amended).
AB 289 (Oropeza); 2001 Stat. Ch. 321.

"I didn't like it. But I had to have it. It was like my seizure
medication.... If I didn't have the heroin, I was going to be real
sick. "'

I. INTRODUCTION

After suffering from headaches and muscular pain caused by epileptic
seizures, Sue decided to try heroin." She used heroin for the first time after a
friend, a heroin dealer, told her he had "something that will take the pain away." 3
A year and a half later, Sue still chased away the pain of her epilepsy with heroin
on a daily basis.4
Unfortunately, in her attempts to quit, heroin caused her much more intense
pain than epilepsy ever did.5 Every time Sue tried to quit "cold turkey" she had
the shakes and sweats. 6 She lost muscle control and began screaming for drugs
and had to "shoot up" just to "calm her[self] down. 7
Sue is not alone; there are approximately 600,000 heroin addicts in the
United States.8 Of these, approximately 115,000 utilize Methadone Maintenance
1. Janet Firshein, Sue: A Family's Battle with Heroin Addiction, PBS Online, available at http:Ilwww.
pbs.org/wnet/closetohome/stories/html/sue.html, at 2 (last visited June 18, 2001) (quoting Susan, a full-time
housewife and mother) (copy on file with the McGeorge Law Review).
2. Id.
3. Id.
4. Id.
5. Id.
6. Id.
7. Id.
8. Harold Sloves, Drug Treatment for Drug Addiction: Surmounting the Barriers, BEHAV. HEALTH
MGMT., July 1, 2000, 2000 WL 17302429 at 3 (on file with the McGeorge Law Review); Robert Mathias, NIH
Panel Calls for Expanded Methadone Treatment for HeroinAddiction, National Institute on Drug Abuse Notes
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Therapy (MMT). 9 Although doctors prescribe methadone more frequently than

anything else to treat heroin addiction, a number of barriers limit the availability
of methadone treatment.'" Chapter 321 addresses the need to keep MMT
available to heroin addicts by exempting Narcotic Treatment Programs (NTPs),
generally owned by non-physicians, from the ban on the corporate practice of
medicine-prohibiting physicians from being employed by "lay entities"consequently enabling them to comply with the law."

II.

KICKING THE HABIT

Heroin is the most abused and most rapidly acting of the opiates.' 2 Heroin
producers process the substance from morphine, which is extracted from the
seedpod of certain varieties of poppy plants.' 3 When the body metabolizes
heroin,
4
it inverts the conversion process, changing heroin back into morphine.
Addiction to heroin is marked by physical dependence on the drug, which
results in withdrawal symptoms if the addict stops taking it.'5 Withdrawal
symptoms, such as drug craving, restlessness, muscle and bone pain, and
vomiting, may occur within hours after the last use of heroin.' 6 The intense
craving motivates addicts to gradually spend more and more time and energy
scraping together money to buy heroin.
Since heroin is so addictive, it is one of the most difficult drugs to quit "cold
turkey."'' 8 In fact, addicts can experience intense cravings for the drug even years

(Nov./Dec. 1997) at http://www.nida.nih.gov:80/NIDANotes/NNVoll 2N6/NIHPanel.html (on file with the
McGeorge Law Review).
9. Sloves, supra note 8, at 3; see Mathias, supra note 8 (explaining that less than twenty percent of
heroin addicts in the United States are being treated with methadone).
10. Id.
11. See Letter from Glenn Backes, Director, Sacramento Center for Policy Reform, to Helen Thompson,
Chair, California State Assembly Health Committee (Mar. 26, 2001) (on file with the McGeorge Law Review)
(explaining that AB 289 will ensure that patients in substance abuse programs will benefit from a greater variety
of therapies); see also Letter from Donne Brownsey, California Organization of Methadone Providers, to
Members, Senate Business and Professions Committee, California State Assembly (May 2, 2001) [hereinafter
Brownsey Letter 1] (on file with the McGeorge Law Review) (stating that the narrow exemption provided to
narcotic treatment programs by AB 289 will allow the State's most at-risk patients to be able to continue
treatment through the network of clinics that have served them for over twenty-five years),
12. National Institute on Drug Abuse (NIDA), Heroin: Abuse and Addiction, NIDA Research Report
Series, at http://www.nida.nih.gov/ResearchReports/Heroin/heroin2.html#used
[hereinafter NIDA] (last
updated Jan. 24, 2001) (copy on file with the McGeorge Law Review).
13. Id.
14. Id.
15. Id.
16. Office of National Drug Control Policy (ONDCP), Drug Facts: Heroin, Office of the President of
the United States, at http://www.whitehousedrugpolicy.gov/drugfact/heroin/index/html [hereinafter ONDCP]
(last visited June 25, 2001) (copy on file with the McGeorge Law Review).
17. NIDA, supra note 12.
18. Janet Firshein, The Politics of Methadone, PBS Online, at http://www.pbs.org/wnet/close
tohome/policy/html/methadone.html (last visited June 12, 2001) (copy on file with the McGeorge Law Review).
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after the last use.' 9 In order to curb the addiction, treatment facilities regularly
administer methadone to heroin abusers to prevent withdrawal symptoms by
relieving the craving for heroin. ° Methadone has been used to treat heroin
addiction for more than thirty years.2 '
Heroin produces an excess of dopamine in the body, causing a need for an
opiate to continuously occupy the opioid receptor in the brain.22 Specified23
chemicals fit opioid and other brain receptors like a key fits into a lock.
Methadone occupies these receptors and frees the heroin addict from intense
cravings. 24
However, unlike heroin, methadone does not produce a euphoric high. 5
Although patients on MMT do not experience the extreme highs and lows
resulting from changing levels of heroin in the blood, they nevertheless remain
physically dependent on the methadone.26 Methadone has an advantage over
heroin, however, because it frees the addict from the uncontrolled, compulsive,
and disruptive behavior caused by heroin. 21
Methadone is highly effective in treating heroin addiction. 28 A 1994 study of
drug treatment in California found that former heroin users on MMT used fewer
illicit drugs, committed fewer crimes, and were admitted to the hospital far less
than addicts in any other kind of drug treatment. 29 Methadone treatment is also
highly cost-effective. ° Intravenous drug-users are at high risk for contracting
AIDS, and MMT costs significantly less per year, only $5,000, than the lifetime
cost, about $109,000, to treat each intravenous drug-user with AIDS.3' MMT also
has a benefit-cost ratio of four to one.32 This means that four dollars in economic
benefit accrues for every dollar spent on MMT.33

19. Donna Boundy, Profile: Methadone Maintenance-The "Invisible" Success Story, at http:/Iwww.
pbs.org/wnet/closetohome/treatment/html/methprofile.html (copy on file with the McGeorge Law Review).
20. EXECUTIVE OFFICE OF THE PRESIDENT, OFFICE OF NATIONAL DRUG CONTROL POLICY, ONDCP
DRUG POLICY INFORMATION CLEARINGHOUSE FACT SHEET: METHADONE (Apr. 2000) [hereinafter ONDCP
FACT SHEET] (copy on file with the McGeorge Law Review).
21. Id.
22. Id.
23. Leah Ariniello, Brain Briefings, Society for Neuroscience, at http://www.winter.sfn.org/briefings/
opiate.html (last visited July 23, 2001) (copy on file with the McGeorge Law Review) (explaining that brain
receptors are proteins located on nerve cell surfaces).
24. ONDCP FACT SHEET, supra note 20, at 1.
25. Sloves, supra note 8.
26. ONDCP FACT SHEET, supra note 20, at 1.
27. Id.
28. NIDA, supra note 12.
29. Firshein, supra note 18.
30. Id.
31.

Id.

32.
33.

ONDCP FACT SHEET, supra note 20, at 2.
Id.
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Despite the positive results achieved through MMT, several obstacles
hamper access to treatment.14 The negative public perception of MMT is one such
obstacle.35 Some people perceive drug addiction as a moral flaw and believe that
MMT is simply an ineffective narcotic substitute for those too weak-willed to
quit heroin "cold turkey."36
A second obstacle is the strict regulation of NTPs, licensed specialty clinics
treating opiate addiction, that dispense methadone.37 Many states do not even
allow NTPs to exist.38 The Department of Health and Human Services and the
Food and Drug Administration mandate the level of dosages, the manner in
which the dosages are administered, and under what circumstances methadone
may be prescribed.39 In addition, NTPs are stringently regulated by the
Department of Drug and Alcohol Programs (DADP) and the Drug Enforcement
Agency. 40 These regulators require all NTPs to have a Medical Director, a
physician, directing the clinic's medical services and assuming medical
responsibility for all patients. 4 ' Also, "current federal law requires physicians
who work for NTPs to sign an agreement that specifies that the physician is
solely responsible for the prescription of methadone and is held accountable for
all of the patients. 4 2 Such regulations reflect a fear that methadone could be sold
on the black market to heroin addicts. 43 However, Dr. Lewis L. Judd, of the
University of California, San Diego, insists that "laws to control methadone
diversion are no longer necessary" because the drug is not attractive to abusers
since it does not produce a euphoric high."
III. EXISTING LAW
A.

Proposition36

Under Proposition 36, effective July 1, 2001, courts now divert more than
thirty-six thousand non-violent drug possession offenders to drug treatment
instead of sending them to prison. Non-violent drug possession offenses are
34. Sloves, supra note 8, at 1.
35. Id.
36. See id. (describing the "no pain, no gain" attitude of many people toward MMT).
37. Firshein, supra note 18.
38. Id.
39. Id.
40. SENATE RULES COMMII-rEE, COMMITTEE ANALYSIS OF AB 289, at 4 (Aug. 27, 2001).
41. Id.
42. ld. at 5.
43. Paul Recer, Experts Callfor Less Regulation of HeroinAddiction Treatment, ATHENS DAILY NEWS,
(1997) available at http://www.athensnewspapers.com/1997/112097/1120.a3heroin.html (last visited Sept. 7,
2001) (copy on file with the McGeorge Law Review).
44. Id.
45. Proposition36: Drugs, Probationand Treatment Program,Analysis by the Legislative Analyst, 3
(Nov. 2000), available at http://vote2000.ss.ca.gov/VoterGuide/text/text-analysis-36.htm (last visited Sept. 7,
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defined as "felony or misdemeanor criminal charge[s] for being under the
influence of illegal drugs or for possessing, using, or transporting illegal drugs
for personal use."' This definition excludes possession for sale, production, or
manufacture of illegal drugs. Therefore, persons convicted of using or
possessing heroin for their own personal use fall within the provisions of
Proposition 36 and may consequently be sent to NTPs for detoxification and
rehabilitation.48
B. The CorporatePracticeof Medicine Doctrine
Under existing law, corporations have no professional rights, privileges, or
powers.4 9 The Medical Practice Act prohibits corporations, including NTPs, from
practicing medicine. ° In order to guard against non-physicians controlling the
practice of medicine, the Medical Practice Act requires that the entity providing
medical services be owned by a physician-controlled medical corporation or an
individual physician.' A corporation under the control of non-physicians cannot
own or be in control of an entity that delivers physician-supervised medical
care.12 Consequently, an overwhelming majority of NTPs, 144 out of 147 in
California, violate the prohibition against the corporate practice of medicine
because physicians or surgeons do not own them. 3
The purpose of the ban is to prevent a "conflict between the professional
standards and obligations of the doctors and the profit motive of the corporation
employer. 5 4 Two fundamental public policy concerns stem from this general
apprehension surrounding the corporate practice of medicine." First, corporate
employment of physicians may "reduce physician autonomy over medical
judgments" as a result of corporate laypersons' influence over physician
judgments 6 Second, physicians employed by corporations "may experience a
sense of divided loyalty between their profit-seeking employer and their
treatment-seeking patients. 57

2001) (copy on file with the McGeorge Law Review).

46.

Id. at 2.

47.

Id.

48.
49.

See id. (defining non-violent drug possession offenses).
CAL. Bus. & PROF. CODE § 2400 (West 1990).

50.

Conrad v. Med. Bd. of Cal., 48 Cal. App. 4th 1038, 1042, 55 Cal. Rptr. 2d 901,902 (1996); see CAL.

Bus. & PROF. CODE § 2000 (West 1990) (naming Chapter 5 the "Medical Practices Act").
51.

CAL. Bus. & PROF. CODE § 2000.

52. Id.
53. SENATE RULES COMMITTEE, COMMITrEE ANALYSIS OF AB 289, at 3-4 (Aug. 27, 2001).
54. People ex rel. State Bd. of Med. Exam'rs v. Pac. Health Corp. 82 P.2d 429,431, 12 Cal. 2d 156, 160
(1938).
55. See Sara Mars, The Corporate Practiceof Medicine: A Callfor Action, 7 HEALTH MATRIX 241, 249
(1997) (stating the policy reasons which support the ban of the corporate practice of medicine).
56. Id.
57. Id.
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Although California strictly enforces the corporate practice of medicine
doctrine, the Legislature created exceptions to the general ban.58 These exceptions
include: nonprofit corporations; professional corporations, partnerships, and
group practices owned and managed by physicians or surgeons; medical schools;
and health maintenance organizations (HMOs).59
In 2000, the Medical Board of California (Medical Board) recognized that
NTPs did not fit into any of the above exceptions and advised the DADP of this
problem. 6° In response, the Legislature enacted Chapter 321, creating an
exemption for NTPs, as a solution to this technical violation of California law. 6 ,
IV. CHAPTER 321

Chapter 321 embodies a narrow exception to the prohibition of the corporate
practice of medicine.62 Under the provisions of Chapter 321, NTPs are free to
employ physicians and charge for professional services rendered by them.63
However, NTPs may not interfere with, control, or otherwise direct a physician's
or surgeon's professional judgment.64 This responds to the concern that NTPs
owned by lay people might attempt to control the decisions of physicians. 65
Chapter 321 also ensures that the NTPs will no longer violate state law
because it eliminates the technical problem that all clinics must be owned or
operated by physicians or surgeons.66 The Medical Board's interpretation of the
law prior to Chapter 321, that all NTPs must be owned and operated by a
physician or surgeon, meant that the vast majority of NTPs were violating the
prohibition. 67 Amending section 2401 of the Business and Professions Code to
provide a narrow exception from the ban on the corporate practice of medicine

58. See generally CAL. Bus. & PROF. CODE § 2401 (West 1990 & Supp. 2002) (listing the exceptions of
the ban on the corporate practice of medicine).
59. See CAL. Bus. & PROF. CODE § 2401 (exempting clinics operated primarily for the purpose of
medical education by a public or private nonprofit university medical school); CAL. Bus. & PROF. CODE § 2402
(West 1990) (establishing that the provisions of section 2400 do not apply to a medical or podiatry corporation
practicing pursuant to the Moscone-Knox Professional Corporation Act). See generally CAL. HEALTH &
SAFETY CODE § 1340 (West 2000) (setting forth the Knox-Keene Health Care Service Plan Act of 1975); 36
CAL. JUR. 3D, Healing Arts and Institutions § 14 (1997) (explaining the basic provisions and purpose of the
Knox-Keene Health Care Service Plan Act).
60. SENATE RULES COMMITTEE, COMMITTEE ANALYSIS OF AB 289, at 4 (Aug. 27, 2001).
61. Brownsey Letter 1,supra note 11, at 1.
62. ASSEMBLY THIRD READING, FLOOR ANALYSIS OF AB 289, at 2 (Feb. 16, 2001).
63. CAL. Bus. & PROF. CODE § 2401 (c) (amended by Chapter 321).
64. Id.
65. ASSEMBLY COMMITrEE ON HEALTH, COMM17EE ANALYSIS OF AB 289, at 3 (Apr. 3, 2001).
66. See Brownsey Letter 1, supra note 11, at I (stating that, according to COMP, because there have not
been problems with the dispensing of methadone in treatment programs, both the Medical Board and the DADP
agree that a very specific and narrow exemption for NTPs would eliminate the technical problem of the clinics
not being owned by a physician or surgeon).
67. Id.
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for NTPs fixes this technical problem.
V. PROPOSITION

68

36 AND ITS IMPACT ON NTPs UNDER CHAPTER 321

The Medical Board is influential in correcting NTPs' technical violation of
the corporate practice of medicine ban.6 ' The Medical Board cautiously supported
Chapter 321, because it was concerned that consumers might be inadequately
protected in the expanding NTP market under Proposition 36, which channels
non-violent drug offenders into treatment. 0 The Medical Board specifically did
not want for-profit clinics excluded from the ban on the corporate practice of
medicine.7
However, the Medical Board's fears of a flood of applications for proposed
71
for-profit NTPs have not been substantiated. In fact, no applications for a new
NTP have been submitted to the Medical Board thus far.73 The lack of new
applications for NTPs is a result of assurances from the DADP that the number of
NTPs will not increase; there will simply be an increase in the number of people
being treated by them.74 Therefore, based on the DADP's assurances that the
number of NTPs will not increase and the DADP's additional assurance that
NTPs will continue to be extensively regulated, the Medical Board no longer
objects to the exclusion of for-profit NTPs from the ban on the corporate practice
of medicine.75 Consequently, Proposition 36's impact on NTPs is slight, posing
no vexing problems for Chapter 321 to address. 76

68. Id.
69. See Letter from Donne Brownsey, California Organization of Methadone Providers, to Jenny
Oropeza, Assemblymember (Mar. 8, 2001) [hereinafter Brownsey Letter 2] (on file with the McGeorge Law
Review) (stating that the Medical Board originally brought the NTPs' technical violation of the law to the
attention of the Department of Alcohol and Drug Programs last year).
70. Telephone Interview with Linda Whitney, Chief of Legislation, Medical Board of California (June
27, 2001) [hereinafter Whitney Interview I] (notes on file with the McGeorge Law Review).
71. Id.; see supra Part ILI.A (discussing Proposition 36).
72. See Telephone Interview with Linda Whitney, Chief of Legislation, Medical Board of California
(MBC) (Sept. 4, 2001) [hereinafter Whitney Interview 2] (notes on file with the McGeorge Low Review)
(stating that the MBC thought there would be a huge increase in NTPs, but no applications for NTPs have been
submitted so far).
73. Id.
74. Telephone Interview with Linda Whitney, Chief of Legislation, Medical Board of California (Dec.
21, 2001) [hereinafter Whitney Interview 3] (notes on file with the McGeorge Law Review).
75. Id.
76. See Whitney Interview 2, supra note 72 (explaining that, despite the Medical Board's apprehensions,
no applications have been received so far for new NTPs attempting to fill the increase in demand under
Proposition 36).
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VI. THE IMPACT OF CHAPTER 321
While its impact on NTPs is significant, the practical impact of Chapter 321
on consumers is slight." Chapter 321 simply legalizes what NTPs have been
doing for over thirty years-treating heroin addicts with methadone maintenance
therapy. 78 NTPs are still required to have a physician as a Medical Director who
oversees the clinic's medical services and assumes responsibility for all
patients. 79 Additionally, NTPs continue to be the only licensed specialty clinics
permitted to dispense methadone."0 Essentially, Chapter 321 protects NTPs from
jeopardy." Without this legislation, the 144 non-physician-owned NTPs would
be forced to become physician-owned to comply with the corporate practice
prohibition.
In addition to Chapter 321's modest practical effects, it likewise places little
demand on existing public policy. 3 First, Chapter 321 addresses the policy
concern of reduced physician autonomy over medical, judgments, because it
explicitly forbids NTPs from interfering with the doctor's professional judgment
in any manner.~" Second, the structure of NTPs ensures that physicians do not
feel a sense of "divided loyalty" between their corporate employer and their
patients, because the Medical Director of each NTP, a physician, is vested with
ultimate authority over all medical decisions. 5 Since doctors within NTPs answer
to another doctor for medical decisions, rather than a8 corporation,
patient welfare
6
profit.
a
yield
to
order
in
sacrificed
be
to
is less likely

77. See Brownsey Letter 1, supra note 67 (advocating the narrow exemption of NTPs from the corporate
practice of medicine ban by emphasizing that NTPs have been treating heroin addicts for over twenty-five
years).
78.

SENATE RULES COMMITrEE, COMMITTEE ANALYSIS OF AB 289, at 5 (Aug. 27, 2001).

79. Id. at 4.
80. See id. (explaining that NTPs are stringently regulated by the State through licensing by the
Department of Alcohol and Drug Programs and the Drug Enforcement Administration because NTPs dispense a
"controlled substance," methadone, which must be prescribed only at a licensed specialty clinic (NTP)).
81. See id. at 5 (stating that forcing NTPs to comply with the ban on the corporate practice of medicine
would jeopardize their existence).
82. See id. (setting forth the California Organization of Methadone Providers' argument that the
alternative of requiring the 144 non-physician-owned NTPs to become physician-owned, to comply with the
corporate practice prohibition, is impossible and would jeopardize the existence of most of these programs).
83. See People ex rel. State Bd. of Med. Exam'rs v. Pac. Health Corp., 82 P. 2d 429, 431, 12 Cal. 2d
156, 160 (1937) (discussing the policy reasons for the existence of the corporate practice of medicine ban).
84. CAL. Bus. & PROF. CODE § 2401(c) (amended by Chapter 321).
85.

SENATE RULES COMMITTEE, COMMITTEE ANALYSIS OF AB 289, at 4 (Aug. 27, 2001).

86. See id. (stating that all medical services provided by NTPs must be under the direction of a
physician, the Medical Director).
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VII. CONCLUSION
NTPs have operated for over thirty years, employing physicians to provide
medical services." During this period of time, no problems have been reported."
These programs serve a critical need in our community. 9 Without NTPs, many
heroin addicts would be helpless in conquering their addictions. 90 However, the
assistance provided under these programs technically violated the law for thirty
years. 9' Chapter 321 frees NTPs from this technical violation of the law and
allows them to be exempted from the general ban on the corporate practice of
medicine. 92 Because NTPs have treated heroin addicts with methadone for over
thirty years without any problems, the public clearly benefits from Chapter 321,
which enables them to comply with the law and keep their doors open.93

87. Id. at 5.
88. Id.
89. See Sloves, supra note 8 (stating that there are over 600,00 heroin addicts nationwide).
90. See Firshein, supra note 18 (explaining that heroin is one of the most difficult drugs to quit "cold
turkey"); see also NIDA, supra note 12 (advocating methadone as an effective treatment for heroin addiction).
91. Brownsey Letter 1, supra note 11.
92. Id.
93. See SENATE RULES COMMITTEE, COMMITTEE ANALYSIS OF AB 289, at 5 (Aug. 27, 2001)
(summarizing the California Organization of Methadone Providers' assertion that passing AB 289 will allow
NTPs to continue to provide medical and drug treatment services in California).

